Cargando…
The effects of enhancing angiotensin converting enzyme in myelomonocytes on ameliorating Alzheimer’s-related disease and preserving cognition
This review examines the role of angiotensin-converting enzyme (ACE) in the context of Alzheimer’s disease (AD) and its potential therapeutic value. ACE is known to degrade the neurotoxic 42-residue long alloform of amyloid β-protein (Aβ(42)), a peptide strongly associated with AD. Previous studies...
Autores principales: | Danziger, Ron, Fuchs, Dieu-Trang, Koronyo, Yosef, Rentsendorj, Altan, Sheyn, Julia, Hayden, Eric Y., Teplow, David B., Black, Keith L., Fuchs, Sebastien, Bernstein, Kenneth E., Koronyo-Hamaoui, Maya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326285/ https://www.ncbi.nlm.nih.gov/pubmed/37427403 http://dx.doi.org/10.3389/fphys.2023.1179315 |
Ejemplares similares
-
Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation
por: Kasindi, Arielle, et al.
Publicado: (2022) -
Retinal Vasculopathy in Alzheimer’s Disease
por: Shi, Haoshen, et al.
Publicado: (2021) -
Effects of IL-34 on Macrophage Immunological Profile in Response to Alzheimer's-Related Aβ(42) Assemblies
por: Zuroff, Leah R., et al.
Publicado: (2020) -
Alzheimer’s Retinopathy: Seeing Disease in the Eyes
por: Mirzaei, Nazanin, et al.
Publicado: (2020) -
Activated Bone Marrow-Derived Macrophages Eradicate Alzheimer's-Related Aβ(42) Oligomers and Protect Synapses
por: Li, Songlin, et al.
Publicado: (2020)